JPMORGAN CHASE & CO - ALDER BIOPHARMACEUTICALS INC ownership

ALDER BIOPHARMACEUTICALS INC's ticker is and the CUSIP is 014339AA3. A total of 41 filers reported holding ALDER BIOPHARMACEUTICALS INC in Q1 2018. The put-call ratio across all filers is - and the average weighting 0.3%.

Quarter-by-quarter ownership
JPMORGAN CHASE & CO ownership history of ALDER BIOPHARMACEUTICALS INC
ValueSharesWeighting
Q3 2019$5,540,000
+3406.3%
5,000,000
+2757.1%
0.00%
Q1 2018$158,000175,0000.00%
Other shareholders
ALDER BIOPHARMACEUTICALS INC shareholders Q1 2018
NameSharesValueWeighting ↓
Lion Point Capital, LP 52,517,000$50,131,0004.53%
Mohican Financial Management, LLC 1,250,000$1,196,0003.90%
Redmile Group, LLC 25,000,000$23,865,0000.70%
WOLVERINE ASSET MANAGEMENT LLC 32,195,000$30,920,0000.42%
PFM Health Sciences, LP 17,213,000$16,517,0000.36%
SSI INVESTMENT MANAGEMENT LLC 2,750,000$2,626,0000.22%
Rock Springs Capital Management LP 5,000,000$4,798,0000.18%
Partner Investment Management, L.P. 137,000$131,0000.15%
PALISADE CAPITAL MANAGEMENT, LP 4,000,000$3,830,0000.12%
DAFNA Capital Management LLC 250,000$240,0000.10%
View complete list of ALDER BIOPHARMACEUTICALS INC shareholders